InNexus Biotechnology, Inc.
IXSBF
$0.00
$0.000.00%
OTC PK
| 03/31/2011 | 12/31/2010 | 09/30/2010 | 06/30/2010 | 03/31/2010 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 1.53M | 1.97M | 1.97M | 2.24M | 2.40M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 1.74M | 2.44M | 2.67M | 3.25M | 3.38M |
| Operating Income | -1.74M | -2.44M | -2.67M | -3.25M | -3.38M |
| Income Before Tax | -4.15M | -5.15M | -5.78M | -6.35M | -6.07M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -4.15 | -5.15 | -5.78 | -6.35 | -6.07 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -4.15M | -5.15M | -5.78M | -6.35M | -6.07M |
| EBIT | -1.74M | -2.44M | -2.67M | -3.25M | -3.38M |
| EBITDA | -1.34M | -2.05M | -2.24M | -2.78M | -2.93M |
| EPS Basic | -0.03 | -0.04 | -0.05 | -0.07 | -0.07 |
| Normalized Basic EPS | -0.02 | -0.03 | -0.03 | -0.04 | -0.04 |
| EPS Diluted | -0.03 | -0.04 | -0.05 | -0.07 | -0.07 |
| Normalized Diluted EPS | -0.02 | -0.03 | -0.03 | -0.04 | -0.04 |
| Average Basic Shares Outstanding | 551.16M | 489.95M | 430.91M | 379.51M | 343.13M |
| Average Diluted Shares Outstanding | 551.16M | 489.95M | 430.91M | 379.51M | 343.13M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |